Skip to content
Back to resident companies

Octagon Therapeutics

Investment areas

  • Biotech / Life Sciences
Founders & Leadership
Isaac Stoner
Peter Yu
Fred Ausubel
Headquarters
Providence, Rhode Island

Developing better medicines for severe autoimmune disease by restoring immune homeostasis.

The Tough Tech problem we are solving

Current treatments for autoimmune disease damage healthy immune functioning, often putting patients at risk, and limiting the effectiveness of most medicines.

About our solution

Octagon has generated new insights into the biology that drives autoimmunity, enabling the next generation of treatments.